To see whether the hypermorphic Kdm8 variants have an even stronger anti-metastatic effect, we performed orthotopic tumor studies using Kdm8 knockout 688M and 606T PDA cells. This evidence concerns the gene KDM8 and Patent ductus arteriosus.